secwatch.observer — SEC 8-K summary
======================================

Issuer:     Omega Therapeutics, Inc. (—)
CIK:        0001850838
Form:       8-K
Filed at:   2025-02-24T23:59:59+00:00
Accession:  0001193125-25-033500
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.01, 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Omega Therapeutics files Ch. 11, stalking horse asset sale to Flagship affiliate for $11.5M, Nasdaq delisting
--------------------------------------------------------------------------------

- Filed Chapter 11 on Feb 10, 2025; entered Stalking Horse APA with PM08-B (Flagship affiliate) for $11.46M credit bid.
- Nasdaq notified delisting due to Chapter 11 filing; trading suspended Feb 25, 2025; Company not appealing.
- Proposed sale process: bid deadline April 1, 2025; auction April 3; sale hearing April 10.
- Company operates as debtor-in-possession under Bankruptcy Court jurisdiction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850838/000119312525033500/0001193125-25-033500-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850838/000119312525033500/d80395d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-033500

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer